McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
807.63
+3.04 (0.38%)
At close: Oct 29, 2025, 4:00 PM EDT
810.00
+2.37 (0.29%)
After-hours: Oct 29, 2025, 7:05 PM EDT
McKesson Revenue
McKesson had revenue of $97.83B in the quarter ending June 30, 2025, with 23.39% growth. This brings the company's revenue in the last twelve months to $377.60B, up 20.35% year-over-year. In the fiscal year ending March 31, 2025, McKesson had annual revenue of $359.05B with 16.22% growth.
Revenue (ttm)
$377.60B
Revenue Growth
+20.35%
P/S Ratio
0.27
Revenue / Employee
$7,403,824
Employees
51,000
Market Cap
100.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 359.05B | 50.10B | 16.22% |
| Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
| Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
| Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
| Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
MCK News
- 13 days ago - Nike and 3 More Companies Raising the Alarm About Tariff Costs - Barrons
- 15 days ago - The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage. - Barrons
- 18 days ago - McKesson Corporation Transforming Towards High-Margin Operations: Why I Choose To Buy - Seeking Alpha
- 18 days ago - McKesson: Strategic Shift To High-Growth Oncology And Prescription Tech Signals Long Opportunity - Seeking Alpha
- 4 weeks ago - See How McKesson Shares Rise with Money Flows - FXEmpire
- 5 weeks ago - McKesson Corporation (MCK) Analyst/Investor Day Transcript - Seeking Alpha
- 5 weeks ago - McKesson lifts annual profit forecast on plans to focus on high-margin businesses - Reuters
- 5 weeks ago - McKesson Corporation Highlights Strategic Growth Strategies and Unveils Updated Long-term Financial Targets at Investor Day - Business Wire